| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2013 | CA2852042A1 Tamper resistant immediate release formulations |
| 09/05/2013 | US20130231599 Antimicrobial adhesive formulation and film dressings having an antimicrobial adhesive |
| 09/05/2013 | US20130231519 1H-Pyrrolo[2,3 b]pyridine derivatives |
| 09/05/2013 | US20130231518 Compounds and compositions for mitigating tissue damage and lethality |
| 09/05/2013 | US20130231490 Method for preparing water-soluble polymer derivatives bearing an n-succinimidyl ester |
| 09/05/2013 | US20130231470 Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd) |
| 09/05/2013 | US20130231395 Methods for treating alzheimer's disease |
| 09/05/2013 | US20130231394 Antimicrobial wound dressing |
| 09/05/2013 | US20130231390 Pharmaceutical composition of ibuprofen for injection |
| 09/05/2013 | US20130231387 Prevention of proteomic and genomic damage by dicarbonyl substrates of glo 1 |
| 09/05/2013 | US20130231384 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 09/05/2013 | US20130231379 Agent for fungal dermatitis |
| 09/05/2013 | US20130231376 Defensin-like molecules as novel antimicrobial agents |
| 09/05/2013 | US20130231372 Small Molecule Inhibitors Of P-type ATPases |
| 09/05/2013 | US20130231371 Spot-on pesticide composition containing a pyrethroid and macrocyclic lactone |
| 09/05/2013 | US20130231367 Beta2-adrenoreceptor agonists |
| 09/05/2013 | US20130231366 Use of a Novel Alpha-7 Nachr Antagonist to Suppress Pathogenic Signal Transduction in Cancer and Aids |
| 09/05/2013 | US20130231365 Treatment of Inflammation with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with Acetylcholinesterase Inhibitors |
| 09/05/2013 | US20130231364 Modulators of cystic fibrosis transmembrane conductance regulator |
| 09/05/2013 | US20130231363 Alternative forms of the phosphodiesterase-4 inhibitor n-cyclopropyl-1--4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide |
| 09/05/2013 | US20130231362 Mast Cell Stabilizers in the Treatment of Obesity |
| 09/05/2013 | US20130231357 Pharmaceutical compositions containing pemetrexed having extended storage stability |
| 09/05/2013 | US20130231356 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 09/05/2013 | US20130231351 Sir2 regulation |
| 09/05/2013 | US20130231350 Solid dispersion formulations and methods of use thereof |
| 09/05/2013 | US20130231347 Method of treatment with braf inhibitor |
| 09/05/2013 | US20130231346 Methods of treating cancer |
| 09/05/2013 | US20130231343 Compounds and methods for treating multiple sclerosis |
| 09/05/2013 | US20130231335 Inhibitors of polo-like kinase |
| 09/05/2013 | US20130231329 Benzazole Derivatives as Histamine H4 Receptor Ligands |
| 09/05/2013 | US20130231327 Substituted Spiro-Amide Compounds |
| 09/05/2013 | US20130231326 Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 09/05/2013 | US20130231320 Substituted amide compound |
| 09/05/2013 | US20130231318 Ocular implant made by a double extrusion process |
| 09/05/2013 | US20130231317 Dhea bioadhesive controlled release gel |
| 09/05/2013 | US20130231316 Drug Combination Comprising a Selective Serotonin Reuptake Inhibitor and a Glucocorticoid Receptor Antagonist for the Treatment of Depression |
| 09/05/2013 | US20130231315 Modified 4-phenyl-pyridine derivatives |
| 09/05/2013 | US20130231314 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione |
| 09/05/2013 | US20130231313 Substituted phenylacetate and phenylpropane amides and use thereof |
| 09/05/2013 | US20130231312 Treatment of type ii diabetes and diabetes-associated diseases with safe chemical mitochondrial uncouplers |
| 09/05/2013 | US20130231309 Treatment of inflammation and organ dysfunction |
| 09/05/2013 | US20130231308 Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome |
| 09/05/2013 | US20130231307 Novel antiviral acyclic nucleoside phosphonates |
| 09/05/2013 | US20130231305 Method of Modulating Protein 14-3-3 Functionality By Facilitating or Inhibiting Phosphorylation |
| 09/05/2013 | US20130231304 Boron-containing small molecules as anti-protozoal agent |
| 09/05/2013 | US20130231302 Antimicrobial solutions |
| 09/05/2013 | US20130231301 Combination of checkpoint kinase i inhibitors and wee i kinase inhibitors |
| 09/05/2013 | US20130231300 Purified Crocetin Compound And Method For Treating, Inhibiting, And/Or Prophylaxis of Cancer, Such As Pancreatic Cancer |
| 09/05/2013 | US20130231298 Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides |
| 09/05/2013 | US20130231297 Dietary supplement for improving visual performance |
| 09/05/2013 | US20130231296 New drug combinations for the treatment of malaria |
| 09/05/2013 | US20130231292 Synergistic anti-proliferation activity of TAS-108 with mTOR inhibitors against cancer cells |
| 09/05/2013 | US20130231290 Methods of diagnosing and treating neurodegenerative diseases |
| 09/05/2013 | US20130231286 Use of Prolactin Receptor Antagonist and Chemotherapeutic Drug for Treating Ovarian Cancer |
| 09/05/2013 | US20130231282 Methods for administering hypoglycemic agents |
| 09/05/2013 | US20130231276 Combination Of An Aminoacyl-tRNA Synthetase Inhibitor With A Further Antibacterial Agent For Attenuating Multiple Drug Resistance |
| 09/05/2013 | US20130231266 METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 09/05/2013 | US20130230920 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
| 09/05/2013 | US20130230596 Abuse-Resistant Oral Dosage Forms And Method Of Use Thereof |
| 09/05/2013 | US20130230595 Methods of Using Multilayer Magnetic Micelle Compositions |
| 09/05/2013 | US20130230594 Compositions with antibacterial and wound healing activity |
| 09/05/2013 | US20130230592 Novel omega-3 and omega-6 fatty acid compositions and uses thereof |
| 09/05/2013 | US20130230589 Pharmaceutical formulations useful in the treatment of insomnia |
| 09/05/2013 | US20130230588 Controlled release compositions |
| 09/05/2013 | US20130230585 Pharmaceutical compounds |
| 09/05/2013 | US20130230583 Modified drugs for use in liposomal nanoparticles |
| 09/05/2013 | US20130230582 Modified drugs for use in liposomal nanoparticles |
| 09/05/2013 | US20130230580 Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration |
| 09/05/2013 | US20130230578 Lipidated immune response modifier compound compositions, formulations, and methods |
| 09/05/2013 | US20130230577 Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies |
| 09/05/2013 | US20130230569 Compositions of r(+) and s(-) pramipexole and methods of using the same |
| 09/05/2013 | US20130230568 Stable Formulations for Lyophilizing Therapeutic Particles |
| 09/05/2013 | US20130230567 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same |
| 09/05/2013 | US20130230560 IgA PRODUCTION PROMOTER |
| 09/05/2013 | US20130230542 ROS-Activated Compounds as Selective Anti-Cancer Therapeutics |
| 09/05/2013 | US20130230541 Anti-igf antibodies |
| 09/05/2013 | US20130230535 Therapy-enhancing glucan |
| 09/05/2013 | US20130230520 Pharmaceutical composition for treating bone diseases which comprises protein comprising frizzled1, frizzled2 or frizzled7 extracellular cysteine-rich domain |
| 09/05/2013 | US20130230514 Compositions of pd-1 antagonists and methods of use |
| 09/05/2013 | US20130230512 Inhibitors of the atb(0,+) transporter and uses thereof |
| 09/05/2013 | US20130230511 Biomarkers for response to tyrosine kinase pathway inhibitors in cancer |
| 09/05/2013 | US20130230506 Methods for increasing intracellular activity of hsp70 |
| 09/05/2013 | US20130230503 Method and preparation for the treatment or prevention of anxiety or neurogenesis |
| 09/05/2013 | US20130230501 Cycloalkyl-Substituted Imidazole Derivative |
| 09/05/2013 | US20130230492 Genetic inhibition by double-stranded rna |
| 09/05/2013 | US20130230489 Paediatric Compositions For Treating Multiple Sclerosis |
| 09/05/2013 | US20130230486 Compositions and methods to induce targeted apoptosis |
| 09/05/2013 | US20130230485 Methods for Treating Patients Undergoing Multi-Cycle Chemotherapy |
| 09/05/2013 | US20130230472 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 09/05/2013 | US20130230463 SUPERPARAMAGNETIC NANOPARTICLES WITH PEG SUBSTITUTED alpha-HYDROXY PHOSPHONATE SHELLS |
| 09/05/2013 | US20130230458 Cell Permeable Inhibitors of Anaphase Promoting Complex |
| 09/05/2013 | US20130230457 Thermosensitive Nanoparticle Formulations and Method of Making The Same |
| 09/05/2013 | US20130230453 Diagnosis and treatment of brain tumors |
| 09/05/2013 | US20130230452 CELL PERMEABLE NANOCONJUGATES OF SHELL-CROSSLINKED KNEDEL (SCK) AND PEPTIDE NUCLEIC ACIDS ("PNAs") WITH UNIQUELY EXPRESSED OR OVER-EXPRESSED mRNA TARGETING SEQUENCES FOR EARLY DIAGNOSIS AND THERAPY OF CANCER |
| 09/04/2013 | EP2634581A1 Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 09/04/2013 | EP2634190A1 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors |
| 09/04/2013 | EP2634189A1 Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors |
| 09/04/2013 | EP2634188A1 Fused aminodihydropyrimidine derivative |
| 09/04/2013 | EP2634187A1 Deuterated morphinane compounds |
| 09/04/2013 | EP2634186A1 Naphthyridine derivative |